| 产品描述: | Abl 选择性抑制剂;Abl Selective Inhibitors;;InformationAST-487 (NVP-AST487), a N,N'-diphenyl urea,is an ATP competitive inhibitor ofFlt3with ki of 0.12 μM.Besides FLT3, AST487 also inhibitsRET,KDR,c-KIT,and c-ABL kinasewith IC50 values below 1 μM.TargetsRET ; KDR ; c-Kit ; c-Abl ; FLT3 (Cell-free assay) ; ;; 0.12 μM(Ki) |
| 靶点: |
IC50: 880 nM (RET), 170 nM (KDR), 790 nM (Flt-4), 500 nM (c-Kit), 520 nM (Flt-3), 20 nM (Abl) |
| 体内研究: |
OF1 小鼠单次口服 15 mg/kg AST 487 后,0.5 小时后达到平均血浆峰浓度 (Cmax),为 0.505 μM SE。口服给药后 6 小时内,小鼠血浆中 AST 487 浓度与给药前相似,24 小时 Clast 为 21 nM。口服生物利用度经计算为 9.7%,t1/2 终末消除时间为 1.5 小时。 |
| 参考文献: |
1. Akeno-Stuart N, et al. The RET Kinase Inhibitor NVP-AST487 Blocks Growth and Calcitonin Gene Expression through Distinct Mechanisms in Medullary Thyroid Cancer Cells. Cancer Res. 2007 Jul 15;67(14):6956-64. 2. Weisberg E, et al. Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells. Blood. 2008 Dec 15;112(13):5161-70. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.888 ml |
9.442 ml |
18.884 ml |
| 5 mM |
0.378 ml |
1.888 ml |
3.777 ml |
| 10 mM |
0.189 ml |
0.944 ml |
1.888 ml |
| 50 mM |
0.038 ml |
0.189 ml |
0.378 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |